Analytical Data
-
Gene name
EID3
- Application
-
Alternative Names
NSMCE4B; NSE4B; E1A-like inhibitor of differentiation 3; EID-1-like inhibitor of differentiation 3; Non-structural maintenance of chromosomes element 4 homolog B
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8N140
-
Expression Region
Met1~Tyr333
-
Molecular Weight
46kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EID3, or EID3 (EID-3), is a member of the EID family of proteins, which are known for their roles in transcriptional regulation and cellular processes. Research on EID3 has gained attention due to its involvement in various biological functions, including cell proliferation, differentiation, and response to stress. The protein is characterized by the presence of an EID domain that mediates interactions with other transcriptional co-factors and chromatin remodeling complexes. Recent studies have suggested that EID3 may act as a key regulator in critical pathways, influencing gene expression in both normal and pathological contexts, such as cancer. Understanding the molecular mechanisms by which EID3 exerts its functions can provide insights into its potential roles in development and disease. Furthermore, EID3's interplay with epigenetic modifiers and its specific binding partners highlight its significance in the broader landscape of gene regulation. As researchers continue to unravel the complexities of EID3’s function, it holds promise as a potential therapeutic target for manipulating gene expression patterns in various diseases. This research not only enhances our understanding of fundamental biological processes but also opens avenues for novel interventions in human health and disease.
